EFPIA - NEWSLETTER

EFPIA Newsletter 08 April 2021

Can Europe’s Beating Cancer Plan Make it an Innovation Leader?

EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in Europe, and its potential to boost the continent’s push to catch up with the US and China on biopharmaceutical innovation. Read more on PharmaBoardroom.

Health Innovation: No one left behind

We call on the Commission to create a High-Level Forum on Better Access to Health Innovation as proposed by the European Health Coalition, to develop concrete solutions for the introduction of new technologies into health systems in a way that is sustainable, widely available and accessible to European citizens.

Watch the conference here and read our conclusions.

Events

15 APR 2021

Innovation for Health Hybrid event

On 15-16 April 2021, the 8th edition of Innovation for Health takes place as a hybrid edition.

Learn more →

26 APR 2021

ATMP world tour Virtual Event

Speakers for this event come from all over the world and will present from their extensive knowledge in varied aspects...

Learn more →

What we are reading

Beating COVID-19: Scale-up of vaccine production in Europe 08 April 2021 (LinkedIn)

Joint letter on COVID-19 and cancer 07 April 2021 (ECPC)

Post-Brexit deal welcomed but leaves future relationship with EU far from settled 06 April 2021 (eyenews)

Call for Abstracts for the EHMA 2021 Annual Conference 05 April 2021 (EHMA)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶